We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,150 hedge funds and large institutions have $289B invested in Johnson & Johnson in 2025 Q1 according to their latest regulatory filings, with 253 funds opening new positions, 1,703 increasing their positions, 1,841 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more call options, than puts

Call options by funds: $4.67B | Put options by funds: $2.57B

71% more first-time investments, than exits

New positions opened: 253 | Existing positions closed: 148

55% more funds holding in top 10

Funds holding in top 10: 146226 (+80)

12% more capital invested

Capital invested by funds: $257B → $289B (+$31.9B)

1% more funds holding

Funds holding: 4,1084,150 (+42)

0.4% more ownership

Funds ownership: 72.03%72.43% (+0.4%)

7% less repeat investments, than reductions

Existing positions increased: 1,703 | Existing positions reduced: 1,841

Holders
4,150
Holders Change
+42
Holders Change %
+1.02%
% of All Funds
55.62%
Holding in Top 10
226
Holding in Top 10 Change
+80
Holding in Top 10 Change %
+54.79%
% of All Funds
3.03%
New
253
Increased
1,703
Reduced
1,841
Closed
148
Calls
$4.67B
Puts
$2.57B
Net Calls
+$2.09B
Net Calls Change
+$1.56B
Name Holding Trade Value Shares
Change
Change in
Stake
NO
826
Ninety One
South Africa
$11.3M +$807K +5,157 +8%
CFM
827
Capricorn Fund Managers
United Kingdom
$11.3M -$94.2K -602 -0.9%
SIG
828
Sky Investment Group
Connecticut
$11.2M -$132K -844 -1%
FNT
829
First Nebraska Trust
Nebraska
$11.2M +$659K +4,210 +7%
BCM
830
Blume Capital Management
California
$11.2M -$72.8K -465 -0.7%
SCM
831
Schnieders Capital Management
California
$11.1M -$568K -3,629 -5%
P
832
Pitcairn
Pennsylvania
$11.1M -$9.39M -60,017 -47%
JPMIA
833
J.P. Marvel Investment Advisors
Massachusetts
$11.1M +$20.5K +131 +0.2%
BG
834
Bellevue Group
Switzerland
$11.1M +$1.95M +12,452 +23%
HA
835
Hamel Associates
New Jersey
$11.1M -$25K -160 -0.2%
LFAS
836
Level Four Advisory Services
Texas
$11.1M +$602K +3,845 +6%
XT
837
XTX Topco
Cayman Islands
$11M +$5.9M +37,736 +132%
RDWM
838
Red Door Wealth Management
Tennessee
$11M +$158K +1,008 +2%
CC
839
Courier Capital
New York
$10.9M +$99K +633 +1%
BTI
840
Blue Trust Inc
Georgia
$10.9M +$417K +2,662 +4%
BBA
841
BLB&B Advisors
Pennsylvania
$10.9M -$506K -3,237 -5%
FDP
842
Financiere des Professionnels
Quebec, Canada
$10.9M -$312K -1,994 -3%
RB
843
Rodgers Brothers
Pennsylvania
$10.9M -$47.1K -301 -0.5%
CDDEC
844
Caisse Des Depots Et Consignations
France
$10.9M -$255K -1,627 -2%
AG
845
Advocate Group
Minnesota
$10.8M +$691K +4,414 +7%
ECM
846
Everence Capital Management
Indiana
$10.8M -$393K -2,510 -4%
Impax Asset Management Group
847
Impax Asset Management Group
United Kingdom
$10.8M -$678K -4,333 -6%
MC
848
Mayar Capital
United Kingdom
$10.8M +$250K +1,600 +3%
PR
849
Payden & Rygel
California
$10.8M +$4.37M +27,900 +75%
MSS
850
Mitchell Sinkler & Starr
Pennsylvania
$10.7M -$598K -3,821 -6%

JNJ Hedge Fund Activity: Q1 2025 in Review

4,150 of the 7,462 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2025, worth a combined $289B — up 12% from $257B a quarter earlier.

Buyers outnumbered sellers: 253 funds opened new JNJ positions and 148 closed out — a net gain of 105 holders — while 1,703 added to existing stakes and 1,841 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $2.39B. The largest seller was T. Rowe Price Associates, cutting an estimated $967M.

  • 4,150 institutional investors held Johnson & Johnson (JNJ) as of Q1 2025, up from 4,108 in Q4 2024.
  • Funds reported $289B of Johnson & Johnson stock for Q1 2025, up 12% quarter-over-quarter.
  • 253 funds opened new Johnson & Johnson positions in Q1 2025 and 148 closed out, a net change of +105 holders.
  • The largest Johnson & Johnson buyer in Q1 2025 was JP Morgan Chase, an estimated $2.39B added.
  • The largest Johnson & Johnson seller in Q1 2025 was T. Rowe Price Associates, an estimated $967M sold.

Based on aggregated 13F filings for Q1 2025.